Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis

OBJECTIVES: Mortality and worsening of organ function are desirable endpoints for clinical trials in systemic sclerosis (SSc). The aim of this study was to identify factors that allow enrichment of patients with these endpoints, in a population of patients from the European Scleroderma Trials and Re...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Rheum Dis
Autors principals: Becker, Mike, Graf, Nicole, Sauter, Rafael, Allanore, Yannick, Curram, John, Denton, Christopher P, Khanna, Dinesh, Matucci-Cerinic, Marco, de Oliveira Pena, Janethe, Pope, Janet E, Distler, Oliver
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2019
Matèries:
Systemic Sclerosis
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6788922/
https://ncbi.nlm.nih.gov/pubmed/31227488
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2019-215145
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars